Single cell RNA (scRNA) sequencing, bulk RNA sequencing, multiplexed immunofluorescence (mIF) and flow cytometry were performed on pretreatment and post-resistant tumor samples from EGFR-mutant NSCLC patients received third-generation EGFR-TKIs. Here, EGFR is linked to neoplasm.